ESC Heart Failure

Papers
(The H4-Index of ESC Heart Failure is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Establishing a novel model to assess exercise capacity in chronic heart failure based on stress echocardiography89
Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices66
62
Prediction of cardiac events with non‐contrast magnetic resonance feature tracking in patients with ischaemic cardiomyopathy62
Characteristics and management of very elderly patients with heart failure: a retrospective, population cohort study60
Corrigendum56
Left atrial unloading with an 8 mm septal cutting balloon to treat postcapillary pulmonary hypertension: a case report54
Synchronized diaphragmatic stimulation: a case report of a novel extra‐cardiac intervention for chronic heart failure54
Systolic dysfunction and mortality in critically ill patients: more data are needed to believe in this association!53
Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation53
Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan53
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis52
Editors' highlight picks from 2023 in ESC heart failure50
Blood perfusion status is important in the prognosis of ventricular aneurysm complicated by ventricular septal rupture48
Cardiac involvement in patients recovering from Delta Variant of COVID‐19: a prospective multi‐parametric MRI study43
New insight: particle flow rate from the airways as an indicator of cardiac failure in the intensive care unit42
Impact of age on characteristics, performance measures and outcomes of inpatients for heart failure in Beijing, China41
Cardiogenic shock requiring VA‐ECMO therapy in scorpionism‐induced myocarditis41
Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry41
Circ_0001206 regulates miR‐665/CRKL axis to alleviate hypoxia/reoxygenation‐induced cardiomyocyte injury in myocardial infarction39
Models of cardiovascular surgery biobanking to facilitate translational research and precision medicine38
Health‐related quality of life among transthyretin amyloid cardiomyopathy patients37
Oral iron supplementation in patients with heart failure: a systematic review and meta‐analysis37
Predictive value of global longitudinal strain by left ventricular ejection fraction37
Machine learning‐based model for predicting 1 year mortality of hospitalized patients with heart failure36
Serum angiotensin‐converting enzyme levels indicating early sarcoidosis diagnosis and immunosuppressive therapy efficacy36
Analysis of the serum levels of RIP3 and Drp1 in patients with heart failure36
Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure36
Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fraction35
Risk classification for long‐term mortality among patients with acute heart failure: China PEACE 4YMortality35
Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices35
Atrial fibrillation ablation in patients with arrhythmia‐induced cardiomyopathy: a prospective multicentre study35
Meta‐Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease35
Meta‐analysis of cardiac magnetic resonance in prognosticating left ventricular function in peripartum cardiomyopathy35
Uncovering the genetic links of SARS‐CoV‐2 infections on heart failure co‐morbidity by a systems biology approach35
0.13991713523865